Skip to main content

Table 3 CMR findings

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

 

Controls (n = 20)

Patients (n = 37)

p

LV-EF (%)

65 ± 4

64 ± 10

0.84

LV-EDV (ml)

109 ± 27

122 ± 41

0.38

LV-ESV (ml)

38 ± 13

46 ± 31

0.49

LV-SV

71 ± 15

76 ± 18

0.40

LV-EDD

45 ± 5

48 ± 5

0.08

LA (cm2)

20 ± 3

20 ± 5

0.84

IVS (mm)

10 ± 2

10 ± 2

0.11

PA (mm)

24 ± 4

25 ± 3

0.37

LV mass (g)

85 ± 20

90 ± 25

0.67

LGE

-

16 (43%)

 

epicardial

-

5 (13%)

 

intramural

-

7 (19%)

 

transmural

-

-

 

subendocardial

-

4 (11%)

 

% LV mass

-

6.8 ± 5

 

Native T1 (ms)

952 (923–960)

988 (965–1017)

<0.001

Post-contrast T1 (ms)

524 (500–529)

488 (468–528)

0.03

ECV (%)

24.5 (23–25)

27.5 (26–29)

<0.001

T2 (ms)

49 (48–51)

53 (51–55)

<0.001

  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us